The global cardiometabolic diseases market is witnessing strong expansion driven by the rising prevalence of cardiovascular disease, type 2 diabetes, obesity, hypertension, and related metabolic disorders. According to industry analysis, the market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in 2025, growing at a CAGR of 4% during 2026–2034 .
This growth is...